WallStreetZenWallStreetZen

NASDAQ: HOTH
Hoth Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for HOTH

Based on 3 analysts offering 12 month price targets for Hoth Therapeutics Inc.
Min Forecast
$3.00+299.47%
Avg Forecast
$4.00+432.62%
Max Forecast
$5.00+565.78%

Should I buy or sell HOTH stock?

Based on 3 analysts offering ratings for Hoth Therapeutics Inc.
Strong Buy
Strong Buy
1 analysts 33.33%
Buy
2 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their HOTH stock forecasts and price targets.

HOTH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-10-11
lockedlocked$00.00+00.00%2024-09-05
lockedlocked$00.00+00.00%2024-08-16

1 of 1

Forecast return on equity

Is HOTH forecast to generate an efficient return?
Company
N/A
Industry
-784.34%
Market
48.93%

Forecast return on assets

Is HOTH forecast to generate an efficient return on assets?
Company
N/A
Industry
26.21%

HOTH earnings per share forecast

What is HOTH's earnings per share in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$1.18
Avg 2 year Forecast
-$0.87

HOTH vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
HOTH$0.75$4.00+432.62%Strong Buy
BNOX$0.28$8.00+2,757.14%Buy
TRAW$5.22N/AN/A
CDIO$0.21$2.00+852.38%Buy
KTTA$4.78N/AN/A
View Top Biotech Stocks

Hoth Therapeutics Stock Forecast FAQ

Is Hoth Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: HOTH) stock is to Strong Buy HOTH stock.

Out of 3 analysts, 1 (33.33%) are recommending HOTH as a Strong Buy, 2 (66.67%) are recommending HOTH as a Buy, 0 (0%) are recommending HOTH as a Hold, 0 (0%) are recommending HOTH as a Sell, and 0 (0%) are recommending HOTH as a Strong Sell.

If you're new to stock investing, here's how to buy Hoth Therapeutics stock.

What is HOTH's earnings growth forecast for 2024-2025?

(NASDAQ: HOTH) Hoth Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.54%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.87%.

Hoth Therapeutics's earnings in 2024 is -$7,462,109.On average, 1 Wall Street analyst forecast HOTH's earnings for 2024 to be -$8,146,489, with the lowest HOTH earnings forecast at -$8,146,489, and the highest HOTH earnings forecast at -$8,146,489.

In 2025, HOTH is forecast to generate -$6,006,309 in earnings, with the lowest earnings forecast at -$6,006,309 and the highest earnings forecast at -$6,006,309.

What is HOTH's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: HOTH) forecast ROE is N/A, which is considered weak.

What is HOTH's Price Target?

According to 3 Wall Street analysts that have issued a 1 year HOTH price target, the average HOTH price target is $4.00, with the highest HOTH stock price forecast at $5.00 and the lowest HOTH stock price forecast at $3.00.

On average, Wall Street analysts predict that Hoth Therapeutics's share price could reach $4.00 by Oct 11, 2025. The average Hoth Therapeutics stock price prediction forecasts a potential upside of 432.62% from the current HOTH share price of $0.75.

What is HOTH's Earnings Per Share (EPS) forecast for 2024-2025?

(NASDAQ: HOTH) Hoth Therapeutics's current Earnings Per Share (EPS) is -$1.61. On average, analysts forecast that HOTH's EPS will be -$1.18 for 2024, with the lowest EPS forecast at -$1.18, and the highest EPS forecast at -$1.18. In 2025, HOTH's EPS is forecast to hit -$0.87 (min: -$0.87, max: -$0.87).

What is HOTH's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: HOTH) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 26.21%.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.